5 Einträge gefunden

1. Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT.

   1. Alchalby, Haefaa
   2. Badbaran, Anita
   3. Bock, O
   4. Fehse, Boris
   5. Bacher, Ulrike
   6. Zander, Axel R.
   7. Kröger, Nicolaus

   2010 - Forschungsinformationssystem des UKE
2. Quantitative monitoring of NPM1 mutations provides a valid minimal residual disease parameter following allogeneic stem cell transplantation.

   1. Bacher, Ulrike
   2. Badbaran, Anita
   3. Fehse, Boris
   4. Zabelina, Tatjana
   5. Zander, Axel R.
   6. Kröger, Nicolaus

   2009 - Forschungsinformationssystem des UKE
3. JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantation.

   1. Kröger, Nicolaus
   2. Alchalby, Haefaa
   3. Klyuchnikov, Evgeny
   4. Badbaran, Anita
   5. Hildebrandt, York
   6. Ayuketang Ayuk, Francis
   7. Bacher, Ulrike

   2009 - Forschungsinformationssystem des UKE
4. Bone marrow mesenchymal stromal cells remain of recipient origin after allogeneic SCT and do not harbor the JAK2V617F mutation in patients with myelofibrosis.

   1. Bacher, Ulrike
   2. Asenova, Svetlana
   3. Badbaran, Anita
   4. Zander, Axel R.
   5. Alchalby, Haefaa
   6. Fehse, Boris
   7. Kröger, Nicolaus

   2009 - Forschungsinformationssystem des UKE
5. Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells.

   1. Lioznov, Michael
   2. El-Cheikh, J
   3. Hoffmann, Friedericke
   4. Hildebrandt, York
   5. Ayuketang Ayuk, Francis
   6. Wolschke, Christine
   7. Atanackovic, Djordje

   2009 - Forschungsinformationssystem des UKE